Integrated Cannabis Company Inc
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese… Read more
Integrated Cannabis Company Inc (CRPGF) - Total Assets
Latest total assets as of April 2025: $286.85 Billion USD
Based on the latest financial reports, Integrated Cannabis Company Inc (CRPGF) holds total assets worth $286.85 Billion USD as of April 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Integrated Cannabis Company Inc - Total Assets Trend (2014–2024)
This chart illustrates how Integrated Cannabis Company Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Integrated Cannabis Company Inc - Asset Composition Analysis
Current Asset Composition (July 2024)
Integrated Cannabis Company Inc's total assets of $286.85 Billion consist of 72.1% current assets and 27.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.4% |
| Accounts Receivable | $81.56 Billion | 31.6% |
| Inventory | $37.05 Billion | 14.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $8.54 Billion | 3.3% |
| Goodwill | $22.37 Billion | 8.7% |
Asset Composition Trend (2014–2024)
This chart illustrates how Integrated Cannabis Company Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Integrated Cannabis Company Inc's current assets represent 72.1% of total assets in 2024, an increase from 3.3% in 2014.
- Cash Position: Cash and equivalents constituted 6.4% of total assets in 2024, up from 0.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 31.6% of total assets.
Integrated Cannabis Company Inc Competitors by Total Assets
Key competitors of Integrated Cannabis Company Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Integrated Cannabis Company Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Integrated Cannabis Company Inc generates 1.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Integrated Cannabis Company Inc generates $ 1.30 in net profit.
Integrated Cannabis Company Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.41 | 1.37 | 0.00 |
| Quick Ratio | 1.12 | 1.12 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $58.74 Billion | $ 53.62 Billion | $ -647.32K |
Integrated Cannabis Company Inc - Advanced Valuation Insights
This section examines the relationship between Integrated Cannabis Company Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.55 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.5% |
| Total Assets | $257.76 Billion |
| Market Capitalization | $1.03 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Integrated Cannabis Company Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Integrated Cannabis Company Inc's assets grew by 4.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Integrated Cannabis Company Inc (2014–2024)
The table below shows the annual total assets of Integrated Cannabis Company Inc from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-07-31 | $257.76 Billion | +4.45% |
| 2023-07-31 | $246.77 Billion | +14.49% |
| 2022-07-31 | $215.53 Billion | +6.06% |
| 2021-07-31 | $203.22 Billion | +15.18% |
| 2020-07-31 | $176.45 Billion | +10629606.65% |
| 2017-07-31 | $1.66 Million | +45958.66% |
| 2016-07-31 | $3.60K | -2.09% |
| 2015-07-31 | $3.68K | -99.94% |
| 2014-07-31 | $6.27 Million | -- |